Sf9, Baculovirus cells.
Hemopexin, Beta-1B-Glycoprotein, HX, Beta-1B-glycoprotein.
Greater than 90.0% as determined by SDS-PAGE.
Hemopexin produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 448 amino acids (24-462a.a.) and having a molecular mass of 50.4kDa. (Molecular size on SDS-PAGE will appear at approximately 50-70kDa).
Hemopexin is expressed with a 9 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
Hemopexin, Beta-1B-Glycoprotein, HX, Beta-1B-glycoprotein.
Sf9, Baculovirus cells.
ADPTPLPPTS AHGNVAEGET KPDPDVTERC SDGWSFDATT LDDNGTMLFF KGEFVWKSHK WDRELISERW KNFPSPVDAA FRQGHNSVFL IKGDKVWVYP PEKKEKGYPK LLQDEFPGIP SPLDAAVECH RGECQAEGVL FFQGDREWFW DLATGTMKER SWPAVGNCSS ALRWLGRYYC FQGNQFLRFD PVRGEVPPRY PRDVRDYFMP CPGRGHGHRN GTGHGNSTHH GPEYMRCSPH LVLSALTSDN HGATYAFSGT HYWRLDTSRD GWHSWPIAHQ WPQGPSAVDA AFSWEEKLYL VQGTQVYVFL TKGGYTLVSG YPKRLEKEVG TPHGIILDSV DAAFICPGSS RLHIMAGRRL WWLDLKSGAQ ATWTELPWPH EKVDGALCME KSLGPNSCSA NGPGLYLIHG PNLYCYSDVE KLNAAKALPQ PQNVTSLLGC THHHHHHH.
Hemopexin is a plasma glycoprotein known for its high affinity for binding heme, a component of hemoglobin. It plays a crucial role in the body’s defense mechanism against heme-induced oxidative stress and inflammation. The recombinant form of hemopexin, produced in Sf9 insect cells, has garnered significant attention for its potential therapeutic applications.
Hemopexin is composed of a single 60-kDa peptide chain . It binds heme with exceptional affinity, forming a 1:1 complex at low heme concentrations and a 2:1 complex at higher concentrations . This binding is pivotal in conditions such as malaria, sickle cell disease, thalassemia, hemorrhage, and hemorrhagic stroke .
The recombinant production of hemopexin involves the use of Sf9 insect cells, a widely used system for producing recombinant proteins. This method ensures high yield and purity of the protein, making it suitable for therapeutic applications. The recombinant hemopexin produced in Sf9 cells retains the structural and functional characteristics of the native protein, including its high affinity for heme binding .
Hemopexin’s ability to scavenge free heme makes it a promising candidate for treating conditions associated with hemolysis and heme-induced toxicity. Studies have shown that recombinant hemopexin can effectively bind heme, reducing its pro-inflammatory and oxidative effects . This property is particularly beneficial in managing hemolytic disorders and conditions involving excessive heme release.